These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19275764)

  • 1. GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation.
    Dorfmueller HC; Borodkin VS; Schimpl M; van Aalten DM
    Biochem J; 2009 May; 420(2):221-7. PubMed ID: 19275764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases.
    Dorfmueller HC; Borodkin VS; Schimpl M; Zheng X; Kime R; Read KD; van Aalten DM
    Chem Biol; 2010 Nov; 17(11):1250-5. PubMed ID: 21095575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds.
    Dorfmueller HC; van Aalten DM
    FEBS Lett; 2010 Feb; 584(4):694-700. PubMed ID: 20026047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of cellular O-GlcNAcylation level by a potent and selective O-GlcNAcase inhibitor based on tetrahydroimidazopyridine scaffold.
    Li T; Li Z; Li J; Wang J; Guo L; Wang PG; Zhao W
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6854-7. PubMed ID: 23058883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
    Li J; Li Z; Li T; Lin L; Zhang Y; Guo L; Xu Y; Zhao W; Wang P
    Biochemistry (Mosc); 2012 Feb; 77(2):194-200. PubMed ID: 22348480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative Disorders.
    Martínez-Viturro CM; Trabanco AA; Royes J; Fernández E; Tresadern G; Vega JA; Del Cerro A; Delgado F; García Molina A; Tovar F; Shaffer P; Ebneth A; Bretteville A; Mertens L; Somers M; Alonso JM; Bartolomé-Nebreda JM
    J Med Chem; 2020 Nov; 63(22):14017-14044. PubMed ID: 33197187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the structural origin of the substrate sequence independence of O-GlcNAcase using a combination of molecular docking and dynamics simulation.
    Martin JC; Fadda E; Ito K; Woods RJ
    Glycobiology; 2014 Jan; 24(1):85-96. PubMed ID: 24134879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-glcNAcylation levels.
    Dorfmueller HC; Borodkin VS; Schimpl M; Shepherd SM; Shpiro NA; van Aalten DM
    J Am Chem Soc; 2006 Dec; 128(51):16484-5. PubMed ID: 17177381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human OGA binds substrates in a conserved peptide recognition groove.
    Schimpl M; Schüttelkopf AW; Borodkin VS; van Aalten DM
    Biochem J; 2010 Nov; 432(1):1-7. PubMed ID: 20863279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel glucopyranoside C2-derived 1,2,3-triazoles displaying selective inhibition of O-GlcNAcase (OGA).
    Igual MO; Nunes PSG; da Costa RM; Mantoani SP; Tostes RC; Carvalho I
    Carbohydr Res; 2019 Jan; 471():43-55. PubMed ID: 30412832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive inhibition of O-GlcNAcase isoforms by an alpha-GlcNAc thiolsulfonate.
    Kim EJ; Amorelli B; Abdo M; Thomas CJ; Love DC; Knapp S; Hanover JA
    J Am Chem Soc; 2007 Dec; 129(48):14854-5. PubMed ID: 17994748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into a strategy for attenuating AmpC-mediated beta-lactam resistance: structural basis for selective inhibition of the glycoside hydrolase NagZ.
    Balcewich MD; Stubbs KA; He Y; James TW; Davies GJ; Vocadlo DJ; Mark BL
    Protein Sci; 2009 Jul; 18(7):1541-51. PubMed ID: 19499593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutant O-GlcNAcase as a probe to reveal global dynamics of protein O-GlcNAcylation during Drosophila embryonic development.
    Mariappa D; Selvan N; Borodkin V; Alonso J; Ferenbach AT; Shepherd C; Navratilova IH; vanAalten DMF
    Biochem J; 2015 Sep; 470(2):255-262. PubMed ID: 26348912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ac
    Wang H; Guo J; Wang N; Wang J; Xue Q; Wang J; Liu W; Liu K; Cao X; Zhao W; Xi R; Niu Y; Wang P; Li J
    Bioorg Med Chem Lett; 2019 Mar; 29(6):802-805. PubMed ID: 30713024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.
    Laczy B; Marsh SA; Brocks CA; Wittmann I; Chatham JC
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1715-27. PubMed ID: 20833964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcase: Emerging Mechanism, Substrate Recognition and Small-Molecule Inhibitors.
    Elbatrawy AA; Kim EJ; Nam G
    ChemMedChem; 2020 Jul; 15(14):1244-1257. PubMed ID: 32496638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MK-8719, a Novel and Selective
    Wang X; Li W; Marcus J; Pearson M; Song L; Smith K; Terracina G; Lee J; Hong KK; Lu SX; Hyde L; Chen SC; Kinsley D; Melchor JP; Rubins DJ; Meng X; Hostetler E; Sur C; Zhang L; Schachter JB; Hess JF; Selnick HG; Vocadlo DJ; McEachern EJ; Uslaner JM; Duffy JL; Smith SM
    J Pharmacol Exp Ther; 2020 Aug; 374(2):252-263. PubMed ID: 32493725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
    Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
    PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
    Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
    Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.